alexa Complementary and Alternative Medicine (CAM) in Chronic Kidney Disease (CKD): More Evidence Needed | Open Access Journals
ISSN: 2327-5162
Alternative & Integrative Medicine
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Complementary and Alternative Medicine (CAM) in Chronic Kidney Disease (CKD): More Evidence Needed

Shamsuddin N1*, Gnanasan S2, Karuppanan M2 and Farooqui M3

1Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

2Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam Campus, Shah Alam, Selangor, Malaysia

3Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Unaizah, Qassim, Saudi Arabia

*Corresponding Author:
Noorasyikin Shamsuddin
Department of Pharmacy, Faculty of Medicine, University of Malaya
50603 Lembah Pantai, Kuala Lumpur, Malaysia
Tel: 6037967751
Fax: 603-79674964
E-mail: [email protected]

Received Date: October 03, 2016; Accepted Date: October 14, 2016; Published Date: October 16, 2016

Citation: Shamsuddin N, Gnanasan S, Karuppanan M, Farooqui M (2016) Complementary and Alternative Medicine (CAM) in Chronic Kidney Disease (CKD): More Evidence Needed. Altern Integr Med 5:223. doi:10.4172/2327-5162.1000223

Copyright: © 2016 Shamsuddin N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Alternative & Integrative Medicine

Letter to Editor

Dear Editor,

Chronic Kidney Disease (CKD) is an irreversible condition that is now becoming a global threat worldwide. The overall prevalence of CKD in the United States is expected to rise from 13% between 1999 to 2004 to 16.7% in 2030 [1]. In Malaysia, it was reported that 2.5 million of Malaysian has been diagnosed with CKD and there is a steady increase of 500,000 to 600,000 patients annually [2]. As this condition is irreversible, the control of blood pressure, glucose, cholesterol and renal replacement therapy serve as the cornerstone of treatment of CKD.

The use of Complementary and Alternative Medicine (CAM) has been extensively reported in patients with chronic diseases, such as cancer, hypertension, diabetes mellitus and asthma. Interestingly, only a handful of studies have been carried out to determine the prevalence of CAM use in different stages of CKD [3-10]. The prevalence of CAM use reported from these studies ranged from 24 - 64 percent. The studies focused on different subtypes of CKD, but were mostly conducted in patients with advanced stage of CKD (dialysis patients) [4-7,10]. The high prevalence of CAM use may be due to unaffordable treatment options, such as renal replacement therapy, especially in low and middle-income countries Albeit routinely advised to abstain themselves from using herbs in view of their failing kidney, herbs are reported to be the most common form of CAM used by CKD patients [6,8-10]. The reasons why CKD patients are using CAM are due to strong influence from family and friends, as well as perceived benefits of the CAM recommended [11]. Many studies revealed low disclosure rates (10-30%) of their CAM use to the attending physicians [3,6,8,9].

Conspicuous use of herbal medicine may be a growing threat to CKD patients. The risks of using herbs in CKD patients include worsening of kidney functions, as demonstrated to be caused by a few herbs that contain aristolochic acids as one of the active biocompounds. We would like to draw attention on the risks posed by some herbal medicines, especially in Chinese herbal medicine that may contain renal toxic herbs. The available herbal products are mostly not well regulated and have no clear statement of content and medicallyrelated information. This condition has worsened with various marketing strategies of herbal companies through mass and social media that leads to surge of public interests in the use of herbal medicine regardless of their low credibility.

On the other side of the coin, a few compounds like curcumin and resveratrol have been shown to possess renoprotective effects by modulating inflammation processes. The potential benefits of herbs are mainly derived from in vivo studies. More clinical studies are needed to determine the renoprotective effects in patients. CAM may also help CKD patients in slowing the progression of renal failure and alleviating some of the symptoms of CKD, such as pruritus, fatigue, depression and uremic bruising [12].

CKD has been known to significantly impair the quality of life of the patients. A review by Soni et al. [13] stated that even patients who are at earlier stages of CKD (stage 1 and 2), already had a decreased health-related quality of life (HRQOL) compared to the normal population. The efficacy of mind-body medicine, like acupuncture, acupressure, yoga and Tai-chi in improving HRQOL of CKD patients have been highlighted in a few studies, but many of the studies either suffer from poorly designed methodology or small sample size. It is also unclear whether patients use CAM to restore their kidney functions or to treat CKD-related symptoms, such as pruritus, anemia, sexual dysfunction or depression. Therefore, we strongly urged more studies to be carried out to ascertain the real reason of CAM usage in CKD patients and whether there is any significant improvement in the HRQOL of CKD patients after using CAM. It is imperative that future studies are well-designed, so that more evidences on efficacy and safety data are produced which could eventually improve CKD patients HRQOL.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 8229
  • [From(publication date):
    December-2016 - Jun 29, 2017]
  • Breakdown by view type
  • HTML page views : 8145
  • PDF downloads :84

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version